These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 23401559)

  • 1. Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway.
    Boyle LH; Hermann C; Boname JM; Porter KM; Patel PA; Burr ML; Duncan LM; Harbour ME; Rhodes DA; Skjødt K; Lehner PJ; Trowsdale J
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3465-70. PubMed ID: 23401559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential interaction of MHC class I with TAPBPR in the absence of glycosylation.
    Neerincx A; Boyle LH
    Mol Immunol; 2019 Sep; 113():58-66. PubMed ID: 30077416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of TAPBPR and Tapasin to MHC class I is mutually exclusive.
    Hermann C; Strittmatter LM; Deane JE; Boyle LH
    J Immunol; 2013 Dec; 191(11):5743-50. PubMed ID: 24163410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and dynamic studies of TAPBPR and Tapasin reveal the mechanism of peptide loading of MHC-I molecules.
    Margulies DH; Jiang J; Natarajan K
    Curr Opin Immunol; 2020 Jun; 64():71-79. PubMed ID: 32402827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomes.
    van Hateren A; Elliott T
    Curr Opin Immunol; 2023 Aug; 83():102340. PubMed ID: 37245412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst.
    Hermann C; van Hateren A; Trautwein N; Neerincx A; Duriez PJ; Stevanović S; Trowsdale J; Deane JE; Elliott T; Boyle LH
    Elife; 2015 Oct; 4():. PubMed ID: 26439010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAPBPR: a new player in the MHC class I presentation pathway.
    Hermann C; Trowsdale J; Boyle LH
    Tissue Antigens; 2015 Mar; 85(3):155-66. PubMed ID: 25720504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAPBPR mediates peptide dissociation from MHC class I using a leucine lever.
    Ilca FT; Neerincx A; Hermann C; Marcu A; Stevanović S; Deane JE; Boyle LH
    Elife; 2018 Nov; 7():. PubMed ID: 30484775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the human MHC-I peptide-loading complex.
    Blees A; Januliene D; Hofmann T; Koller N; Schmidt C; Trowitzsch S; Moeller A; Tampé R
    Nature; 2017 Nov; 551(7681):525-528. PubMed ID: 29107940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for calnexin in the assembly of the MHC class I loading complex in the endoplasmic reticulum.
    Diedrich G; Bangia N; Pan M; Cresswell P
    J Immunol; 2001 Feb; 166(3):1703-9. PubMed ID: 11160214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of function of tapasin, a critical major histocompatibility complex class I assembly factor.
    Rizvi SM; Raghavan M
    Traffic; 2010 Mar; 11(3):332-47. PubMed ID: 20070606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer.
    Wearsch PA; Cresswell P
    Nat Immunol; 2007 Aug; 8(8):873-81. PubMed ID: 17603487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex.
    Peaper DR; Wearsch PA; Cresswell P
    EMBO J; 2005 Oct; 24(20):3613-23. PubMed ID: 16193070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of the tapasin homologue TAPBPR.
    Neerincx A; Boyle LH
    Curr Opin Immunol; 2017 Jun; 46():97-102. PubMed ID: 28528220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ins and Outs of TAPBPR.
    Ilca T; Boyle LH
    Curr Opin Immunol; 2020 Jun; 64():146-151. PubMed ID: 32814254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules.
    Ilca FT; Neerincx A; Wills MR; de la Roche M; Boyle LH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9353-E9361. PubMed ID: 30213851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex.
    Elliott T; Williams A
    Immunol Rev; 2005 Oct; 207():89-99. PubMed ID: 16181329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap.
    McShan AC; Devlin CA; Morozov GI; Overall SA; Moschidi D; Akella N; Procko E; Sgourakis NG
    Nat Commun; 2021 May; 12(1):3174. PubMed ID: 34039964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex.
    Hughes EA; Cresswell P
    Curr Biol; 1998 Jun; 8(12):709-12. PubMed ID: 9637923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.